baber/WOPTO huggingface dataset:
Patent AU-612700-B2 (AU)
Title: Olefin polymer compositions for use with water systems
Inventor: HAYDEN EARL E
IPC: C08K5/13
Filed: 1988-09-29
Granted: 1991-07-18
Abstract: An olefin polymer composition having improved resistance to deterioration in the presence of chlorinated and nonchlorinated water and having improved resistance to temperatures of 0 DEG C to 100 DEG C, comprises a blend of:   (a) 93 to 99.5 percent by weight of an isotactic polymer of an alpha olefin of 2 to 6 carbon atoms; (b) 0.05 to 0.50 percent by weight of a hindered amine UV stabilizer;   (c) 0.05 to 1.1 by weight of a hindered phenolic thermal stabilizer having a molecular weight above 530;   (d) 0 to 0.5 percent by weight of a nucleating agent;   (e) 0 to 4 percent by weight of a pigment;   (f) 0 to 3.0 percent by weight of a filler; and   (g) >0 to 3.0 percent by weight of a chelating agent.   The composition can be used to fabricate pipes for carrying water and coatings for wire and cable.
Patent AU-756753-B2 (AU)
Title: Method for producing an anhydrite III or alpha based hydraulic bonding agent
Inventor: COUTURIER JEAN
IPC: B23B15/00
Filed: 1999-02-12
Granted: 2003-01-23
Abstract: A hydraulic binder is produced by firing gypsum and then rapid cooling the product from the firing temperature to below 80[deg]C in less than 2 minutes. Production of a hydraulic binder, which is based on natural or artificial calcium sulfate (gypsum, sulfo-gypsum, phospho-gypsum or titano-gypsum) and which contains more than 70% stable and soluble alpha anhydrite (anhydrite-III), is carried out by subjecting gypsum to (a) a firing or soaking step in which the gypsum is heated from ambient temperature to 220-350[deg]C; and (b) rapid cooling to below 80[deg]C in less than 2 minutes to stabilize the alpha anhydrite by fixing of its crystallographic structure. An independent claim is also included for a hydraulic binder acting as an alpha anhydrite based cement and obtained by the above process, the binder containing more than 70% stable and soluble alpha anhydrite.
Patent AU-657794-B2 (AU)
Title: Novel carboxyalkyl derivatives useful as inhibitors of enkephalinase and ACE
Inventor: WARSHAWSKY ALAN M
IPC: C07D471/04
Filed: 1992-09-22
Granted: 1995-03-23
Abstract: The present invention relates to compounds of the formula <CHEM>  wherein   B<5> and B<6>   are each independently hydrogen; hydroxy; -OR<6> wherein R<6> is a C<5>-C<8> alkyl or an Ar-Y group wherein Ar is aryl and Y is a hydrogen or C<5>-C<8> alkyl; or, where B<5> and B<6> are attached to adjacent carbon atoms, B<5> and B<6> can be taken together with said adjacent carbons to form a benzene ring or methylenedioxy; A   is a bond, methylene or oxygen, sulfur or NR<8> or NCOR psi wherein R<8> is hydrogen, a C<5>-C<8> alkyl or an Ar-Y- group and R psi  is -CF<7>, a C<5>-C<5><4> alkyl or an Ar-Y- group; R<7>   is hydrogen or -CH<6>OC(O)C(CH<7>)<7>; R<5>   is hydrogen, C<5>-C<8> alkyl or -CH<6>OC(O)-C(CH<7>)<7>; and n   is an integer 1 to 3, which are useful as inhibitors of enkephalinase and ACE.
Patent AU-664201-B2 (AU)
Title: A method for treatment of patients with chronic liver disease
Inventor: SKAKKEBAEK NIELS ERIK
IPC: A61P3/02
Filed: 1992-08-18
Granted: 1995-11-09
Abstract: PCT No. PCT/DK92/00245 Sec. 371 Date Mar. 2, 1994 Sec. 102(e) Date Mar. 2, 1994 PCT Filed Aug. 18, 1991 PCT Pub. No. WO93/04694 PCT Pub. Date Mar. 18, 1993.Patients with chronic liver disease and consequently very low concentrations of IGF-1 in the blood, in spite of increased GH concentrations, are treated with periodically injections of hGH for a period both parameters being individually adjusted for the patients.
Patent AU-778132-B2 (AU)
Title: Stable salts of novel derivatives of 3,3-diphenylpropylamines
Inventor: MEESE CLAUS
IPC: C07C219/28
Filed: 2000-11-15
Granted: 2004-11-18
Abstract: N,N-Diisopropyl-3-(2-acyloxy-5-hydroxymethyl)-3-phenylpropylammonium salts (I) are new. Diphenylpropylamine derivative salts of formula (I) are new. [Image] R : 1-6C alkyl, 3-10C cycloalkyl or optionally substituted phenyl; X -> : residue of an organic or inorganic acid. Independent claims are included for new diphenylpropylamine derivatives of formulae (II). [Image] Q 1 : COOMe; and Q 2 : H or benzyl; or Q 1 : CH 2OH; and Q 2 : H. ACTIVITY : Uropathic; spasmolytic. MECHANISM OF ACTION : None given.
Patent AU-735545-B2 (AU)
Title: Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
Inventor: CHRISTOPHERSEN PALLE
IPC: C07C275/40
Filed: 1997-05-26
Granted: 2001-07-12
Abstract: The present patent application relates to compounds having formula (I) or a pharmaceutically acceptable salt thereof wherein one of R1, R2 and R3 is a non-cyclic acidic group having a pKa value below 8 or a group which is in vivo convertible to such a group; R4, R5 and the other two of the substituents R1, R2 and R3 are each independently selected from hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, hydroxy, halogen, trifluoromethyl, trifluoromethoxy, cyano, nitro, amnino, and aryl, aralkyl, arylamino, aryloxy, aryl-CO-, or heteroaryl, wherein the aryl and heteroaryl groups may be substituted one or more times with substituents selected from alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, hydroxy, alkoxy, halogen, trifluoromethyl, trifluoromethoxy, cyano, nitro and amino; or R3 and R4 or R4 and R5 together form a fused 4- to 7-membered carbocyclic ring which may be unsaturated, or partially or fully saturated, while the other substituents R1, R2, R3, R4 and R5 are as defined above; Y is -CO-, -CS-, -SO2-, or -C(=N-R8)-, wherein R8 is hydrogen, alkyl, or cyano; X is -NH-, -CH2-NH-, or -SO2-NH-; Z is NR6, O, -CH=CH-, -C=C-, -N=CH-, or -CH=N-; wherein R6 is hydrogen, or alkyl; R11, R12, R13, R14 and R15 are each independently selected from hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, hydroxy, halogen, trifluoromethyl, trifluoromethoxy, cyano, nitro, amino, -NHSO2-R7, -COOR7, -SO2N(R7)2, -SO2OR7 and -CO-R7, wherein R7 is hydrogen alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, aryl or aralkyl; and aryl, aralkyl, arylamino, aryloxy, aryl-CO-, or heteroaryl, wherein the aryl and heteroaryl groups may be substituted one or more times with substituents selected from alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, hydroxy, alkoxy, halogen, trifluoromethyl, trifluoromethoxy, cyano, nitro and amino; or one of R11 and R12, R12 a
Patent AU-621104-B2 (AU)
Title: Method and system for decompressing color video encoded data
Inventor: MUSIC JOHN
IPC: H04N11/04
Filed: 1989-03-25
Granted: 1992-03-05
Abstract: The method and system of decompressing color video data for use in a video information communication system utilizes digitized run length and color information to represent the pixels in the scan lines of a video picture frame. The digitized signals are of a first digital word size, the run length portion of the digitized signal is of a second digital word size and the color portion of the digitized signal is of a third digital word size. The run length portion and the three digital color components data are stored in an array in a memory to represent the pixels in the scan lines of the video picture frame; and the color portion of the digitized signal is converted into three digital color components of fourth, fifth, and sixth digital word sizes. The memory consists of a pingpong A buffer memory and a pingpong B buffer memory, from which the run length and color information is transferred to a display drawing engine which generates a series of converted digital color components representing individual pixels, which is then converted to analog form for display on a monitor.
Patent AU-664239-B2 (AU)
Title: Metering device
Inventor: BRAITHWAITE PHILIP WILSON
IPC: A61M13/00
Filed: 1993-02-18
Granted: 1995-11-09
Abstract: The invention provides an inhaler 140 for delivering a substance in a finely divided form. The inhaler 140 comprising an air intake and an inhalation passage 144 communicating with the air intake. A receptacle 145 in combination with a metering device having first and second end elements sealing against the inner walls of the receptacle so as to define an intermediate dosing space loaded with a desired volumetric dose of the substance is provided. The relative dimensions of the metering device and receptacle 145 are such that the device has a tendency to remain in the receptacle unless actively urged out of it. Indexing means 146 operate to move the receptacle into a position in or adjacent the inhalation passage and means are provided for urging the metering device at least partially out of the receptacle so as to release the dose of substance contained in the receptacle into the inhalation passage when the receptacle occupies its position in or adjacent the inhalation passage 144. <IMAGE>
Patent AU-742247-B2 (AU)
Title: Trans-xanthophyll ester concentrates of enhanced purity and methods of making same
Inventor: LEVY LUIS W
IPC: A23L1/275
Filed: 1999-04-14
Granted: 2001-12-20
Abstract: Trans-xanthophyll ester concentrates having a trans-xanthophyll ester content of at least four times greater and preferably at least nine times greater than the cis-xanthophyll ester content are obtained. Xanthophyll ester concentrates having a total xanthophyll ester content of at least 40 wt. % and preferably greater than about 55 wt. % are also obtained. A method of obtaining a trans-xanthophyll ester concentrate of high purity includes contacting plant material containing xanthophyll esters with a hydrocarbon solvent for a time sufficient to extract xanthophyll esters from the plant material, separating the hydrocarbon solvent and extract dissolved therein from the remaining plant material, evaporating the hydrocarbon solvent from the dissolved extract to obtain a crude xanthophyll ester concentrate, admixing the crude xanthophyll ester concentrate with an alcohol at approximately ambient temperature to dissolve non-xanthophyll impurities and cis-xanthophyll esters from the concentrate and removing the alcohol containing impurities and cis-xanthophyll esters from the crude trans-xanthophyll concentrate to obtain a purified trans-xanthophyll ester concentrate. By using only the corollas of marigold flowers, lutein ester concentrates of high purity are obtained with pesticide residues absent from the concentrate at parts per billion detection levels.
Patent AU-714636-B2 (AU)
Title: Protein kinase (NPK-110)
Inventor: MANDELKOW ECKHARD
IPC: C12Q1/48
Filed: 1995-10-30
Granted: 2000-01-06
Abstract: The present invention relates to a DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules. The invention further relates to Serine or Theorine residues and epitopes comprising said residues phosphorylated by said NPK on said MAPs, to antibodies specifically binding to said protein kinase, pharmaceutical compositions comprising inhibitors to said protein kinase, in particular for the treatment of Alzheimer's disease and cancer, to diagnostic kits and to in vitro diagnostic methods for the detection of Alzheimer's disease and cancer.
Patent AU-689683-B2 (AU)
Title: Method for fiberizing mineral material with organic material
Inventor: AULT PATRICK L
IPC: C03C25/14
Filed: 1995-11-27
Granted: 1998-04-02
Abstract: A method for fiberizing mineral material with organic material includes centrifuging mineral fibers from molten mineral material with a first spinner rotating about an axis, changing the direction of the mineral fibers to form a downwardly moving veil of mineral fibers, establishing a flow of molten organic material moving downwardly in a first conduit positioned within the veil, and directing the flow of molten organic material to a position beneath the spinner, dividing the flow of molten organic material into a plurality of streams, directing, by means of individual conduits, individual ones of the plurality of streams radially outwardly away from the first conduit, rotating the individual conduits about the axis, centrifuging organic fibers from the molten organic material by means of nozzles at the radially outward ends of the individual conduits, and directing the organic fibers into contact with the veil of mineral fibers.
Patent AU-633516-B2 (AU)
Title: A broiling apparatus, in particular for grilling
IPC: A47J37/12
Filed: 1989-09-05
Granted: 1993-02-04
Abstract: PCT No. PCT/DK89/00207 Sec. 371 Date Apr. 8, 1991 Sec. 102(e) Date Apr. 8, 1991 PCT Filed Sep. 5, 1989 PCT Pub. No. WO90/02508 PCT Pub. Date Mar. 22, 1990.In a frying apparatus, in particular for grilling, an electric heating device with a contact frying surface is positioned in a mainly box-shaped cabinet with an up-turned opening that may be closed at a distance above the contact frying surface by a preferably transparent cover plate. Structure is provided in connection with the cabinet for conditioning the atmosphere above the contact frying surface at a temperature and air humidity suitable for a specific frying operation, together with an air exhaust for the removal of vapor, fatty particles, smoke and smell from the atmosphere. An air flow of a specific quantity and at controlled temperature and passing substantially horizontally is provided across the contact frying surface towards the air exhaust positioned at one lateral wall of the cabinet, a preferably catalytic filtering device being provided in association with the air exhaust.
Patent AU-737122-B2 (AU)
Title: High level expression of proteins
Inventor: SEED BRIAN
IPC: C12P21/02
Filed: 1997-09-18
Granted: 2001-08-09
Abstract: The invention features a synthetic gene encoding a protein normally expressed in a mammalian cell wherein at least one non-preferred or less preferred codon in the natural gene encoding the protein has been replaced by a preferred codon encoding the same amino acid.
Patent AU-615113-B2 (AU)
Title: Process for the preparation of an ethylene/propylene copolymer
Inventor: ANTBERG MARTIN
IPC: C08F210/16
Filed: 1989-10-20
Granted: 1991-09-19
Abstract: The invention relates to a process for the preparation of a predominantly crystalline ethylene/propylene copolymer having less than 15 mol % of propylene units, which can be carried out in liquid propylene as the suspending agent, if metallocene catalyst components of the formulae I, II or III are employed and the partial pressures of ethylene and propylene have a specific ratio.   <IMAGE> (I) <IMAGE> (II)  <IMAGE> (III)  By means of this process, it is possible to increase the possible uses of polymerization plants which work with liquid propylene.
Patent AU-619934-B2 (AU)
Title: Substituted guanidine and amidine compounds, their production and fungicidal use
Inventor: LIEBESCHUETZ JOHN W
IPC: A01N43/54
Filed: 1989-12-18
Granted: 1992-02-06
Abstract: The present invention concerns novel substituted guanidine and amidine compounds, their preparation and their use in the kill and control of fungal organisms which infest plants.
Patent AU-765369-B2 (AU)
Title: Solubilization of 1,3,5-triazine derivatives with N-acyl amino acid esters
Inventor: CANDAU DIDIER
IPC: A61K8/00
Filed: 2002-06-19
Granted: 2003-09-18
Abstract: Compositions containing a 1,3,5-triazine and an N-acylated ester of an amino acid (II).  Compositions containing a 1,3,5-triazine and an N-acylated ester of an amino acid of formula R'1C(O)N(R'2)CH(R'3)-(CH2)nCOOR'4 (II).  n = 0-2; R'1 = 5-21C alkyl or alkenyl; R'2 = H or 1-3C alkyl; R'3 = H, or 1-4C alkyl; and R'4 = 1-10C alkyl, 2-10C alkenyl, or a sterol residue.
Patent AU-624475-B2 (AU)
Title: Cycloaminoalkoxyphenyl derivatives, a process for their preparation as well as the compositions containing them
Inventor: GUBIN JEAN
IPC: C07D401/12
Filed: 1990-02-06
Granted: 1992-06-11
Abstract: The invention relates to cycloaminoalkoxyphenyl derivatives which are active, in particular, in the treatment of pathological syndromes of the cardiovascular system, of general formula: <IMAGE>  in which:  B represents an -S-, -SO- or -SO2- group, R1 and R2, which are identical or different, each represent hydrogen, a methyl or ethyl radical or a halogen, A represents a linear or branched C2-C5 alkylene radical or a 2-hydroxypropylene radical in which the hydroxyl is optionally substituted with a C1-C4-alkyl radical,  Am represents a group: <IMAGE> and Cy represents a group of formula: <IMAGE>
Patent AU-637595-B2 (AU)
Title: Process and apparatus
Inventor: HARRISON GEORGE EDWIN
IPC: C07C67/08
Filed: 1990-01-16
Granted: 1993-06-03
Abstract: Esterification is carried out in a column reactor (14) in which there is a plurality of esterification trays (15) each having predetermined liquid hold-up and containing a charge of a solid esterification catalyst thereon. e.g. an ion exchange resin containing a -SO3H and/or -COOH groups. A liquid phase containing the carboxylic acid component, e.g. a fatty acid mixture, flows down the column reactor from one esterification tray to the next downward one against an upflowing alcohol vapour stream, e.g. methanol vapour. Relatively dry alcohol vapour is injected (21) into the bottom of the column reactor. Water of esterification is removed from the top of the column reactor in the vapour stream (26), whilst ester product is recovered (23) from the sump of the reactor. As the liquid flows down the trays it encounters progressively drier alocohol and the esterification equilibrium reaction is driven further and further towards 100% ester formation. A polishing reactor (304) operated under liquid phase conditions may follow the column reactor, the ester-containing product from which is mixed with further alcohol before admission to the polishing reactor.
Patent AU-612964-B2 (AU)
Title: Insulin derivatives having a charge which is positive compared with the charge of human insulin at neutral pH
Inventor: MARKUSSEN JAN
IPC: C07K14/62
Filed: 1986-03-11
Granted: 1991-07-25
Abstract: Insulin derivatives having a charge which is positive compared with the charge of human insulin at neutral pH, can be used to prepare solutions having prolonged insulin action. In the novel insulin derivatives, a basic amino acid has been substituted in the B27-position and/or a neutral amino acid has been inserted in the A4-, A17-, B13- and/or B21-position. Furthermore, the C-terminal carboxyl group of the B-chain has been blocked with an amido or ester residue.
Patent AU-680642-B2 (AU)
Title: Pulsatile particles drug delivery system
Inventor: CHEN CHIH-MING
IPC: A61K9/56
Filed: 1993-11-02
Granted: 1997-08-07
Abstract: PCT No. PCT/US93/10643 Sec. 371 Date Aug. 16, 1994 Sec. 102(e) Date Aug. 16, 1994 PCT Filed Nov. 2, 1993 PCT Pub. No. WO94/12160 PCT Pub. Date Jun. 9, 1994.Unit dosage form for delivering drugs into the body in a series of sequential, pulsatile releasing events employs conventional pharmaceutical equipment and processes for optimum economy, reliability, and bioavailability. The system can be used with drugs which cannot be released by diffusion through a porous coating, such as water insoluble drugs. A plurality of populations of pellets is provided within a unit dosage form such as a capsule (8) or tablet. The pellets are composed of a core containing the drug (3) and a swelling agent (4) which expands in volume when exposed to water. The core is enclosed within a membrane or coating which is permeable to water. The membrane is composed of a water insoluble and permeable film forming polymer, a water soluble film forming polymer (11) and a permeability reducing agent (14). When the unit dose releases the pellets into the digestive tract, water diffuses through the coating and into the core. As water is taken up by the swelling agent, the core expands, exerting force on the coating until it bursts, releasing the drug. The permeability reducing agent reduces the rate at which water reaches the swelling agent, thereby delaying release time. The water soluble polymer dissolves, weakening the coating so that it bursts sooner. By varying the proportions of the three coating ingredients and/or coating thickness from one pellet population to another, the release timing of the pellets can be very effectively controlled.
Patent AU-672467-B2 (AU)
Title: Machine for sucking up rail ballast
Inventor: THEURER JOSEF
IPC: B61D47/00
Filed: 1994-01-05
Granted: 1996-10-03
Abstract: A machine (1) for taking up ballast from a track ballast bed (2) by suction has a machine frame (5) which is capable of travelling on the track (3) via rail running gear (4) and on which there are provided a suction arrangement (8), having an intake connection (22) with suction opening (23), and a clearing member (9) for transporting the ballast to the suction opening (23), which clearing member cooperates with said suction arrangement and is both height-adjustable and rotatable about a vertical pivot axis (37) via drives (44, 38). The clearing member (9) assigned to the suction arrangement (8) is constructed as an endless clearing chain (30) guided around a horizontally running clearing beam (31) with deflection rollers (32) provided at the ends thereof. The pivot axis (37) is provided at one end (34) of the clearing beam (31) and, in the working position, in the region in front of the sleeper end, and the suction opening (23) of the intake connection (22) is furthermore arranged height-adjustably in the region in front of the sleeper end. <IMAGE>
Patent AU-719856-B2 (AU)
Title: Impact absorbing macadam
Inventor: SPENDLOVE PETER DAVID
IPC: E01C13/02
Filed: 1996-05-23
Granted: 2000-05-18
Abstract: PCT No. PCT/GB96/01240 Sec. 371 Date Mar. 23, 1998 Sec. 102(e) Date Mar. 23, 1998 PCT Filed May 23, 1996 PCT Pub. No. WO96/37658 PCT Pub. Date Nov. 28, 1996An impact absorbing macadam comprises 10 to 75% (preferably 25 to 45%) of a particulate rubber having a particle size of up to 40 mm, 25 to 90% (preferably 45 to 65%) of an aggregate having a particle of up to 40 mm and from 5 to 9% of a polymer modified bituminous binder. Typically such a macadam has a void volume, interconnected or unconnected, of from 5 to 25%. The polymer which modifies the bituminous binder is preferably an unbranched styrene butadiene styrene block copolymer forming about 7% of the modified binder. The macadam is suitable as a base for sports pitches and athletic tracks without a rubber shock pad overlay.
Patent AU-778876-B2 (AU)
Title: Swimming goggles
Inventor: CHIANG HERMAN
IPC: B06B1/06
Filed: 1999-11-12
Granted: 2004-12-23
Abstract: The subject invention relates to the presentation of structural improvement of swimming goggles (1). This comprises of two frames (10,11), two lenses (12,13) contained on the two frames (10,11), a nose bridge (2) joining the two frames, and a headset (3) fitted to the outside of the two frames. It is characterized in that: the nose bridge (2) comprises of a connecting unit (20) and a combining unit (21), with soft material (22) fitted to one side where the connecting unit (20) is in contact with the nose bridge (2); and, the combining unit (21) is located at two sides of the connecting unit (20), whereby the soft material (22) will provide comfortable contact with the nose when the swimming goggles are worn by the user. <IMAGE>
Patent AU-534756-B2 (AU)
Title: Hot melt adhesive comprising copolymers of acrylic or methacrylic acid ester
Inventor: FISCHER HANNES
IPC: C08F220/12
Filed: 1980-10-03
Granted: 1984-02-16
Abstract: A hot melt adhesive having a good thermal stability under load, based on a copolymer of a predominant proportion of acrylates or methacrylates, a minor proportion of acrylic or methacrylic acid amides and further based on acrylic or methacrylic acid compounds, characterized in that the copolymer comprises (a) 85 to 95% by weight of alkyl acrylates and/or methacrylates with 1 to 12 carbon atoms in the alkyl radical, (b) 3 to 10% by weight of acrylamide and/or methacrylamide, (c) 0.2 to 5% by weight of one or more olefinically unsaturated mono- or dicarboxylic acids with up to 5 carbon atoms, the sum of components (a) to (c) amounting to 100%, at a and a process for preparing a multi-layer article, containing said adhesives.